Publisher
Springer Science and Business Media LLC
Reference48 articles.
1. Penn H, Howie AJ, Kingdon EJ, et al.: Scleroderma renal crisis: patient characteristics and long-term outcomes. QJM 2007, 100:485–494.
2. Valentini G, Bencivelli W, Bombardieri S, et al.: European Scleroderma Study Group to define disease activity criteria for systemic sclerosis. III. Assessment of the construct validity of the preliminary activity criteria. Ann Rheum Dis 2003, 62:901–903.
3. Dziadzio M, Usinger W, Leask A, et al.: N-terminal connective tissue growth factor is a marker of the fibrotic phenotype in scleroderma. QJM 2005, 98:485–492.
4. Sato S, Nagaoka T, Hasegawa M, et al.: Serum levels of connective tissue growth factor are elevated in patients with systemic sclerosis: association with extent of skin sclerosis and severity of pulmonary fibrosis. J Rheumatol 2000, 27:149–154.
5. Dziadzio M, Smith RE, Abraham DJ, et al.: Circulating levels of active transforming growth factor beta1 are reduced in diffuse cutaneous systemic sclerosis and correlate inversely with the modified Rodnan skin score. Rheumatology (Oxford) 2005, 44:1518–1524.
Cited by
16 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献